FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q36503619> ?p ?o ?g. }

• Q36503619 description "2012 nî lūn-bûn" @default.
• Q36503619 description "2012年の論文" @default.
• Q36503619 description "2012年論文" @default.
• Q36503619 description "2012年論文" @default.
• Q36503619 description "2012年論文" @default.
• Q36503619 description "2012年論文" @default.
• Q36503619 description "2012年論文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012年论文" @default.
• Q36503619 description "2012년 논문" @default.
• Q36503619 description "article científic" @default.
• Q36503619 description "article scientific" @default.
• Q36503619 description "article scientifique" @default.
• Q36503619 description "articol științific" @default.
• Q36503619 description "articolo scientifico" @default.
• Q36503619 description "artigo científico" @default.
• Q36503619 description "artigo científico" @default.
• Q36503619 description "artigo científico" @default.
• Q36503619 description "artikel ilmiah" @default.
• Q36503619 description "artikull shkencor" @default.
• Q36503619 description "artikulong pang-agham" @default.
• Q36503619 description "artykuł naukowy" @default.
• Q36503619 description "artículo científico publicado en 2012" @default.
• Q36503619 description "artículu científicu espublizáu en 2012" @default.
• Q36503619 description "bilimsel makale" @default.
• Q36503619 description "bài báo khoa học" @default.
• Q36503619 description "naučni članak" @default.
• Q36503619 description "scienca artikolo" @default.
• Q36503619 description "scientific article published on 26 November 2012" @default.
• Q36503619 description "scientific article published on 26 November 2012" @default.
• Q36503619 description "scientific article published on 26 November 2012" @default.
• Q36503619 description "teaduslik artikkel" @default.
• Q36503619 description "tieteellinen artikkeli" @default.
• Q36503619 description "tudományos cikk" @default.
• Q36503619 description "vedecký článok" @default.
• Q36503619 description "vetenskaplig artikel" @default.
• Q36503619 description "videnskabelig artikel" @default.
• Q36503619 description "vitenskapelig artikkel" @default.
• Q36503619 description "vitskapeleg artikkel" @default.
• Q36503619 description "vědecký článek" @default.
• Q36503619 description "wetenschappelijk artikel" @default.
• Q36503619 description "wissenschaftlicher Artikel" @default.
• Q36503619 description "επιστημονικό άρθρο" @default.
• Q36503619 description "мақолаи илмӣ" @default.
• Q36503619 description "наукова стаття, опублікована в листопаді 2012" @default.
• Q36503619 description "научна статия" @default.
• Q36503619 description "научная статья" @default.
• Q36503619 description "научни чланак" @default.
• Q36503619 description "научни чланак" @default.
• Q36503619 description "מאמר מדעי" @default.
• Q36503619 description "مقالة علمية نشرت في 26 نوفمبر 2012" @default.
• Q36503619 description "২৬ নভেম্বর ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q36503619 description "บทความทางวิทยาศาสตร์" @default.
• Q36503619 description "სამეცნიერო სტატია" @default.
• Q36503619 name "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 name "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 name "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 type Item @default.
• Q36503619 label "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 label "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 label "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 prefLabel "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 prefLabel "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 prefLabel "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 P1433 Q36503619-9038706E-6E0A-4F16-8B59-20001751C413 @default.
• Q36503619 P1476 Q36503619-ACBC18EC-0C87-49F4-A4F7-30555B4F529A @default.
• Q36503619 P2093 Q36503619-6052AD3C-239E-4DFA-9A27-B09F0E28FE8C @default.
• Q36503619 P2093 Q36503619-6C0C7D10-7A94-4F95-BC79-BFD2A2B5F402 @default.
• Q36503619 P2093 Q36503619-81CCD7A1-41A3-4E97-865C-8FA956174F78 @default.
• Q36503619 P2093 Q36503619-B11A6C87-F8A2-42D7-8BE6-8500983665B3 @default.
• Q36503619 P2093 Q36503619-B9DC71CB-13AA-45AC-8449-D8F0978CEE2C @default.
• Q36503619 P2860 Q36503619-3EF341BE-128E-4E18-BF95-39CD7FE2DF97 @default.
• Q36503619 P2860 Q36503619-596D4A52-BF5E-49EE-B5C1-8EB62C2CB2EC @default.
• Q36503619 P2860 Q36503619-92FA19E1-1CB6-4885-872D-99DE01E6DA70 @default.
• Q36503619 P2860 Q36503619-BA15D876-A907-4D8D-9C14-C63E979CADF8 @default.
• Q36503619 P2860 Q36503619-DE0CE71E-AB62-44D5-86D8-78276F69D2DB @default.
• Q36503619 P2860 Q36503619-EADDB22C-E486-4FC0-803C-A6C7058080F4 @default.
• Q36503619 P304 Q36503619-32E7439F-99F2-4166-AAA9-6514F131D24E @default.
• Q36503619 P31 Q36503619-D4208FFC-4E91-4BFD-B479-2773AB3B9CBB @default.
• Q36503619 P356 Q36503619-8F2D9DB4-0E0D-4B1C-91E3-4E4F539AB046 @default.
• Q36503619 P407 Q36503619-216C2A9C-AF58-4789-A1ED-FC1EC02DF9DF @default.
• Q36503619 P433 Q36503619-234F0C95-328D-436F-8E83-941CCA8EFE3D @default.
• Q36503619 P478 Q36503619-2229CC96-EEDC-4FCD-8043-3EC4E53A89F4 @default.
• Q36503619 P50 Q36503619-8DB3557F-657F-4128-A3D6-2986B9BAEF34 @default.
• Q36503619 P577 Q36503619-708DDE5D-93B6-4634-84C7-AA486E4FC698 @default.
• Q36503619 P5875 Q36503619-1E61E8E9-AA4A-4ECB-97E0-A863347A2F6A @default.
• Q36503619 P698 Q36503619-2176B707-C139-4622-8C6F-5F530C1EA4A0 @default.
• Q36503619 P8608 Q36503619-27D28291-FB9C-4119-9FBC-768B88D2E312 @default.
• Q36503619 P932 Q36503619-8E2D847C-9F62-4674-AD60-7CF422CF4D62 @default.
• Q36503619 P356 JIDC.1908 @default.
• Q36503619 P698 23277506 @default.
• Q36503619 P1433 Q6295346 @default.
• Q36503619 P1476 "Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program" @default.
• Q36503619 P2093 "Charles Chiedza Maponga" @default.
• Q36503619 P2093 "Gene D Morse" @default.
• Q36503619 P2093 "Marvelous Sibanda" @default.

• next